Metachromatic leukodystrophy is a rare genetic disorder that mainly affects young children and results in severe neurological symptoms accompanied by a loss of motor and intellectual capacities. At ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...

Add Yahoo as a preferred source to see more of our stories on Google. A new medical treatment that costs more than $4 million for metachromatic leukodystrophy (MLD) was approved recently by the FDA.

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons. The medicine, ...

Millie Grennan and Joe Somers, of Long Beach, have two children with the genetic disorder metachromatic leukodystrophy, MLD.

The US Food and Drug Administration (FDA) has approved the first gene therapy for metachromatic leukodystrophy (MLD), a rare and debilitating genetic disease affecting the brain and nervous system.

The approval makes atidarsagene autotemcel (arsa-cel [Lenmeldy]; Orchard Therapeutics) the first approved treatment for metachromatic leukodystrophy, a disease caused by a mutation in the ARSA gene ...

A 7-year-old Sarasota boy has been diagnosed with a rare disease. Now, he is up north getting treatment that will cost nearly $5 million and will last into the fall. He was in class at school when his ...

SARASOTA, Fla. (WWSB) - A Sarasota family is sharing their story in hopes of raising awareness about a rare and devastating ...

Metachromatic leukodystrophy is a rare genetic disorder that affects between 1 and 9 people out of 100,000 and manifests itself mainly in childhood and adolescence—with 10 to 20% of cases observed in ...

A new medical treatment that costs more than $4 million for metachromatic leukodystrophy (MLD) was approved recently by the FDA. MLD was recognized as a disease in the early 1900s, although specifics ...